| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/1998 | US5736573 Lipid and water soluble derivatives of drugs |
| 04/07/1998 | US5736571 Guerbet meadowfoam esters in personal care |
| 04/07/1998 | US5736570 Administering to reduce tumor necrosis factor (tnfa) levels in mammal; retroviral disease treatment/prophylaxis |
| 04/07/1998 | US5736568 2-(aminoalkoxy) phenylalkylamines with antiinflammatory activity |
| 04/07/1998 | US5736566 Heteroaromatic compounds and crop protection agents containing them |
| 04/07/1998 | US5736564 Endothelin receptor antagonists |
| 04/07/1998 | US5736563 Transcutaneous in vivo activation of photosensitive agents in blood |
| 04/07/1998 | US5736562 Modify function of serotonin in mammals |
| 04/07/1998 | US5736561 Vascular hypertrophy suppressor |
| 04/07/1998 | US5736560 Useful in the treatment of alzheimer's and parkinsons's diseases |
| 04/07/1998 | US5736558 4-(6-fluoro-1,2-benzisoxazolyl)-1 piperidinyl-propoxy-chromen-4-one-one-derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety |
| 04/07/1998 | US5736557 N,N-bis (quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials |
| 04/07/1998 | US5736556 Parkinson*s disease; antidepressants; antiobesity; antinarcolepsy; drug abruse |
| 04/07/1998 | US5736555 Hypotensive agents; fda orange book listed patent for azilsartan medoxomil |
| 04/07/1998 | US5736554 Treating and/or preventing cardiovascular disorders |
| 04/07/1998 | US5736553 Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine |
| 04/07/1998 | US5736549 Hypoxanthine and guanine compounds |
| 04/07/1998 | US5736548 Cyclic guanosine 3*,5*-monophosphate phosphodiesterase inhibitors; treating heart failure, hypertension |
| 04/07/1998 | US5736544 Naphthylpiperazinyl compounds useful for treating 5HT2B receptor mediated conditions |
| 04/07/1998 | US5736543 Benzoxazines for enhancing synaptic response |
| 04/07/1998 | US5736542 Pharmaceutical compositions containing a staurosporine |
| 04/07/1998 | US5736541 Slurrying impure material in anhydrous ethyl acetate, then crystallization yields pure stable drug for treatment of anxiety, psychological disorders and gastrointestinal disorders |
| 04/07/1998 | US5736539 Inhibitors of farnesyl-protein transferase |
| 04/07/1998 | US5736536 Method for treating vascular leak syndrome |
| 04/07/1998 | US5736534 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents |
| 04/07/1998 | US5736533 Inhibiting colonization of streptococcus pneumoniae, hemophilus influenza or parainfluenza, burkholderia (pseudomonas) cepacia by administering binding inhibiting oligosaccharide |
| 04/07/1998 | US5736532 Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan |
| 04/07/1998 | US5736531 Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| 04/07/1998 | US5736529 Administering to reduce degree of neural apoptosis in mammal due to stroke |
| 04/07/1998 | US5736528 N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists |
| 04/07/1998 | US5736526 Mixed reverse trascriptase inhibitor and hydroxyurea for treatment of hiv virus |
| 04/07/1998 | US5736525 Used for treatemnt of acquired immuno deficiency syndrome with anti-aids drugs selected from 3'-azido-3'-deoxythymidine(azt), dideoxyinosine(ddi), or dideoxycytidine(ddc) |
| 04/07/1998 | US5736522 Chondoprotective agent |
| 04/07/1998 | US5736519 Enhances reconstitution of cells of hematopoietic and immune systems following radiation or chemotherapy induced suppression |
| 04/07/1998 | US5736516 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein protein |
| 04/07/1998 | US5736396 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/07/1998 | US5736392 Composition for transfecting eukaryotic cell comprising peptide-nucleic acid complex and cationic lipid capable of aggregating complex |
| 04/07/1998 | US5736391 HIV gp41 mutants |
| 04/07/1998 | US5736380 From pimelobacter; for foods, cosmetics |
| 04/07/1998 | US5736366 Adsorption of 10-deacetylbaccatin iii from aqueous suspension of ground yew plant (taxus sp.), desorption from substrate by solvent, desolventizing and selective crystallization |
| 04/07/1998 | US5736157 Parenterally administering a therapeutically effective amount of a lipid acceptor |
| 04/07/1998 | US5736156 Anticarcinogenic agent having lactone ring protected from hydrolysis by association with surfactant or lipid; drug delivery, water solubility, nontoxic |
| 04/07/1998 | US5736154 Multilayered, intra-lesional, interferon delivery which doesn't pass into blood stream; for treatuble carcinomas |
| 04/07/1998 | US5736151 Antibiotic oil suspensions |
| 04/07/1998 | US5736149 Allergenic proteins and peptides from johnson grass pollen |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736128 Cosmetic composition for rejuvenation of skin without skin irritation |
| 04/07/1998 | US5736127 Polymeric nitrogen-containing drug salt forms for controlled release |
| 04/07/1998 | US5736126 Liquid transdermal analgesic |
| 04/07/1998 | US5736124 Aerosol formulations containing P134a and particulate medicament |
| 04/07/1998 | CA2154871C Farnesyl:protein transferase inhibitors as anticancer agents |
| 04/07/1998 | CA2146260C Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds |
| 04/07/1998 | CA2146259C Substituted benzylaminoquinuclidines |
| 04/07/1998 | CA2130116C Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/07/1998 | CA2116785C Sustained release organic nitrite therapy |
| 04/07/1998 | CA2084193C 3-amino-2-aryl quinuclidines |
| 04/07/1998 | CA2073189C N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition |
| 04/07/1998 | CA2026775C Halo substituted aminotetralins |
| 04/07/1998 | CA2018229C Carboplatin composition |
| 04/07/1998 | CA2003441C Quinuclidine therapeutic agents |
| 04/07/1998 | CA1339803C Dideoxydidehydrocarbocyclic nucleosides |
| 04/07/1998 | CA1339802C Diarylstrylquinoline diacids |
| 04/03/1998 | CA2216265A1 Method for inhibiting the growth of mammalian cells |
| 04/02/1998 | WO1998013949A2 Method for adapting a receiver to transmission conditions, and the adequate receiver |
| 04/02/1998 | WO1998013526A1 Three component chimeric antisense oligonucleotides |
| 04/02/1998 | WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013399A1 Fluid composition for physiological separations |
| 04/02/1998 | WO1998013373A1 Erythromycin a derivatives |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 04/02/1998 | WO1998013359A1 Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect |
| 04/02/1998 | WO1998013358A1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 04/02/1998 | WO1998013357A1 Benzo[1,4]thiazine derivatives and drugs comprising the same |
| 04/02/1998 | WO1998013355A1 Heterocyclic esters and amides |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013352A1 2-deoxy-2-amino(or 2-methylamino)-d-glucose salts comprising n-arachidonacetic acid and showing anti-microbial activity |
| 04/02/1998 | WO1998013350A1 Qinoline derivatives inhibiting the effect of growth factors such as vegf |
| 04/02/1998 | WO1998013349A2 Heteroaryloxyethylamines as 5-ht1a ligands |
| 04/02/1998 | WO1998013347A1 Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| 04/02/1998 | WO1998013345A1 Insect-repellent formulations |
| 04/02/1998 | WO1998013343A1 Heterocyclic thioesters and ketones |
| 04/02/1998 | WO1998013337A1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 04/02/1998 | WO1998013332A1 Nitrone derivatives |
| 04/02/1998 | WO1998013328A1 Cyclopentenones, process for preparing the same, and the use thereof |
| 04/02/1998 | WO1998013073A1 METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013070A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | WO1998013061A1 Inhibition of 26s and 20s proteasome by indanones |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998013057A1 Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation |
| 04/02/1998 | WO1998013056A1 Beta-glucan products and extraction processes from cereals |
| 04/02/1998 | WO1998013054A1 A method for producing an extract from valeriana officinalis containing high levels of valerenic acid |
| 04/02/1998 | WO1998013049A1 Method for preparing a product in particular for preventing and curing skin diseases, and resulting product |
| 04/02/1998 | WO1998013048A1 Novel methods for inducing proliferation in auditory receptor epithelium |
| 04/02/1998 | WO1998013046A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 04/02/1998 | WO1998013045A1 Cancerous metastasis inhibitors containing uracil derivatives |
| 04/02/1998 | WO1998013044A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors |
| 04/02/1998 | WO1998013043A1 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |